Quick Takeaways
- Rock Springs Capital Management LP filed SCHEDULE 13G/A for Travere Therapeutics, Inc. Common Stock, par value $0.0001 per share (TVTX).
- Disclosed ownership: 5.7%.
- Date of event: 31 Dec 2024.
Quoteable Key Fact
"Rock Springs Capital Management LP disclosed 5.7% ownership in Travere Therapeutics, Inc. Common Stock, par value $0.0001 per share (TVTX) on 31 Dec 2024."
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Rock Springs Capital Management LP | 5.7% | 4,973,649 | 0 | 4,973,649 | /s/ Mark Bussard | Mark Bussard - Member | |
| Rock Springs Capital LLC | 5.7% | 4,973,649 | 0 | 4,973,649 | /s/ Mark Bussard | Mark Bussard - Member | |
| Rock Springs Capital Master Fund LP | 4.8% | 4,180,000 | 0 | 4,180,000 | /s/ Mark Bussard | Mark Bussard - Member | |
| Mark Bussard | 5.7% | 4,973,649 | 0 | 4,973,649 | /s/ Mark Bussard | Mark Bussard | |
| Kris Jenner | 5.7% | 4,973,649 | 0 | 4,973,649 | /s/ Kris Jenner | Kris Jenner |